We are live on ! Find out more
Prudential Financial

Prudential Financial Portfolio holdings

AUM $81.2B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
+27.81%
3 Year Est. Return
+94.87%
5 Year Est. Return
+128.33%
10 Year Est. Return
+450.33%
AUM
$66.2B
AUM Growth
+$2.36B
Cap. Flow
-$4.34B
Cap. Flow %
-6.56%
Top 10 Hldgs %
26.27%
Holding
2,763
New
170
Increased
1,022
Reduced
1,381
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 23.67%
2 Financials 10.79%
3 Healthcare 10.73%
4 Consumer Discretionary 9.54%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESPR
2501
DELISTED
Esperion Therapeutics
ESPR
$99.4K ﹤0.01%
33,260
MBI icon
2502
MBIA
MBI
$288M
$99.2K ﹤0.01%
+16,209
New +$130K
MGNI icon
2503
Magnite
MGNI
$2.65B
$98K ﹤0.01%
10,492
+290
+3% +$2.29K
ARDX icon
2504
Ardelyx
ARDX
$1.24B
$97.7K ﹤0.01%
15,750
+1,460
+10% +$6.55K
KOD icon
2505
Kodiak Sciences
KOD
$2.59B
$93.7K ﹤0.01%
30,808
BKD icon
2506
Brookdale Senior Living
BKD
$3.62B
$90.4K ﹤0.01%
15,529
-9,620
-38% -$45.1K
AIV
2507
Aimco
AIV
$380M
$89.9K ﹤0.01%
11,478
-35,632
-76% -$241K
RIGL icon
2508
Rigel Pharmaceuticals
RIGL
$680M
$89.7K ﹤0.01%
6,186
NWG icon
2509
NatWest
NWG
$71.5B
$89.1K ﹤0.01%
15,830
+1,357
+9% +$7.21K
STTK icon
2510
Shattuck Labs
STTK
$710M
$87K ﹤0.01%
12,200
-5,600
-31% -$15.3K
BCRX icon
2511
BioCryst Pharmaceuticals
BCRX
$2.37B
$86.6K ﹤0.01%
14,465
+460
+3% +$2.67K
CRBU icon
2512
Caribou Biosciences
CRBU
$156M
$85.5K ﹤0.01%
14,924
+2,314
+18% +$11.4K
AVPT icon
2513
AvePoint
AVPT
$2.6B
$84.7K ﹤0.01%
10,315
BTG icon
2514
B2Gold
BTG
$5.16B
$84.2K ﹤0.01%
+26,499
New +$83.6K
PSTX
2515
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$81.9K ﹤0.01%
24,380
CDE icon
2516
Coeur Mining
CDE
$15.6B
$79.3K ﹤0.01%
24,336
+810
+3% +$2.21K
GERN icon
2517
Geron
GERN
$911M
$77.7K ﹤0.01%
36,817
+1,620
+5% +$3.15K
CXDO icon
2518
Crexendo
CXDO
$215M
$76.6K ﹤0.01%
15,800
-4,200
-21% -$11K
XERS icon
2519
Xeris Biopharma Holdings
XERS
$1.44B
$74K ﹤0.01%
31,475
PBYI icon
2520
Puma Biotechnology
PBYI
$406M
$71K ﹤0.01%
16,400
COMP icon
2521
Compass
COMP
$8.27B
$70.7K ﹤0.01%
18,815
MNKD icon
2522
MannKind Corp
MNKD
$1.28B
$70.7K ﹤0.01%
19,421
-26,030
-57% -$99.4K
INFN
2523
DELISTED
Infinera Corporation Common Stock
INFN
$70.2K ﹤0.01%
14,775
+540
+4% +$2.12K
CERS icon
2524
Cerus
CERS
$587M
$67K ﹤0.01%
31,007
+19,390
+167% +$32K
STIM icon
2525
Neuronetics
STIM
$120M
$65K ﹤0.01%
22,400

Similar funds

Prudential Financial's Q4 2023 Portfolio in Review

As of Q4 2023, Prudential Financial held 2,763 positions worth $66.2B, up 3.7% from $63.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Prudential Financial withdrew a net $4.34B in Q4 2023, closing 119 positions and reducing 1,381 holdings. Its most notable exit was Activision Blizzard, an estimated $60.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Prudential Financial opened a new position in Tricon Residential Inc. worth $48.4M.

  • Prudential Financial's largest Q4 2023 buy was Tricon Residential Inc.: 5,310,217 shares worth $48.4M.
  • Prudential Financial added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $1.17B increase.
  • Prudential Financial's biggest Q4 2023 reduction was Microsoft, cutting an estimated $417M.
  • Prudential Financial fully exited Activision Blizzard in Q4 2023, selling an estimated $60.3M.
  • Prudential Financial's ten largest holdings make up 26% of its $66.2B portfolio in Q4 2023.
  • Prudential Financial opened 170 new positions and closed 119 in Q4 2023.
  • Prudential Financial's portfolio value rose 3.7% quarter-over-quarter to $66.2B.

Based on Prudential Financial's 13F filing for Q4 2023, filed 13 Feb 2024.